• Published On : Jul-2016 |
  • Pages : 211 Pages |
  • Format :

Table of Contents:

1. Research Methodology

2. Assumptions and Acronyms

3. Executive Summary

4. Glycobiology Market Overview
   4.1. Introduction
         4.1.1. Glycobiology Market Definition
         4.1.2. Glycobiology Market Taxonomy
   4.2. Glycobiology Market Dynamics
         4.2.1. Drivers
         4.2.2. Restraints
         4.2.3. Opportunity

5. Global Glycobiology Market Forecast
   5.1. Market Value (US$ Mn) Forecast
         5.1.1. Y-o-Y Growth Projections
         5.1.2. Absolute $ Opportunity
   5.2. Glycobiology Market Trends
   5.3. Regional Average Pricing Analysis (2015)

6. Global Glycobiology Market Analysis, By Product Type 
   6.1. Introduction
         6.1.1. Y-o-Y Growth Comparison, By Product Type 
         6.1.2. Market Share & Basis Point (BPS) Analysis, By Product Type 
   6.2. Market Forecast, By Product Type 
         6.2.1. Instruments
                 6.2.1.1. Absolute $ Opportunity
                 6.2.1.2. Market Value (US$ Mn) Forecast
         6.2.2. Enzymes
                 6.2.2.1. Absolute $ Opportunity
                 6.2.2.2. Market Value (US$ Mn) Forecast
         6.2.3. Consumables
                 6.2.3.1. Absolute $ Opportunity
                 6.2.3.2. Market Value (US$ Mn) Forecast
         6.2.4. Reagent Kits
                 6.2.4.1. Absolute $ Opportunity
                 6.2.4.2. Market Value (US$ Mn) Forecast
   6.3. Market Attractiveness Analysis, By Product Type 

7. Global Glycobiology Market Analysis, By Enzyme 
   7.1. Introduction
         7.1.1. Y-o-Y Growth Comparison, By Enzyme 
         7.1.2. Market Share & Basis Point (BPS) Analysis, By Enzyme 
   7.2. Market Forecast, By Enzyme 
         7.2.1. Galactosidases
                 7.2.1.1. Absolute $ Opportunity
                 7.2.1.2. Market Value (US$ Mn) Forecast
                 7.2.1.3. Fucosidases
                 7.2.1.4. Chitinases
                 7.2.1.5. Acetylgalactosaminidase
                 7.2.1.6. Heparinase
                 7.2.1.7. PNGase F
                 7.2.1.8. Others
         7.2.2. GlcNAc Transferases
                 7.2.2.1. Absolute $ Opportunity
                 7.2.2.2. Market Value (US$ Mn) Forecast
                 7.2.2.3. Acetylglucosaminyltransferase
                 7.2.2.4. Exostosin
                 7.2.2.5. Others
         7.2.3. Fucosyltransferases
                 7.2.3.1. Absolute $ Opportunity
                 7.2.3.2. Market Value (US$ Mn) Forecast
         7.2.4. GalNAc Transferases
                 7.2.4.1. Absolute $ Opportunity
                 7.2.4.2. Market Value (US$ Mn) Forecast
         7.2.5. Galactosyl Transferases
                 7.2.5.1. Absolute $ Opportunity
                 7.2.5.2. Market Value (US$ Mn) Forecast
         7.2.6. Glucuronosyltransferases
                 7.2.6.1. Absolute $ Opportunity
                 7.2.6.2. Market Value (US$ Mn) Forecast
         7.2.7. Glucosyltransferases
                 7.2.7.1. Absolute $ Opportunity
                 7.2.7.2. Market Value (US$ Mn) Forecast
         7.2.8. Pentosyltransferases
                 7.2.8.1. Absolute $ Opportunity
                 7.2.8.2. Market Value (US$ Mn) Forecast
         7.2.9. Carbohydrate Kinases
                 7.2.9.1. Absolute $ Opportunity
                 7.2.9.2. Market Value (US$ Mn) Forecast
         7.2.10. Neuraminidases
                 7.2.10.1. Absolute $ Opportunity
                 7.2.10.2. Market Value (US$ Mn) Forecast
         7.2.11. Sialyltransferases
                 7.2.11.1. Absolute $ Opportunity
                 7.2.11.2. Market Value (US$ Mn) Forecast
         7.2.12. Others
                 7.2.12.1. Absolute $ Opportunity
                 7.2.12.2. Market Value (US$ Mn) Forecast
   7.3. Market Attractiveness Analysis, By Enzyme 

8. Global Glycobiology Market Analysis, By Application 
   8.1. Introduction
         8.1.1. Y-o-Y Growth Comparison, By Application 
         8.1.2. Market Share & Basis Point (BPS) Analysis, By Application 
   8.2. Market Forecast, By Application 
         8.2.1. Drug Discovery And Development
                 8.2.1.1. Absolute $ Opportunity
                 8.2.1.2. Market Value (US$ Mn) Forecast
         8.2.2. Diagnostic Applications
                 8.2.2.1. Absolute $ Opportunity
                 8.2.2.2. Market Value (US$ Mn) Forecast
                 8.2.2.3. Oncology
                 8.2.2.4. Immunology
                 8.2.2.5. Others
         8.2.3. Industrial Application
                 8.2.3.1. Absolute $ Opportunity
                 8.2.3.2. Market Value (US$ Mn) Forecast
         8.2.4. Therapeutic Application
                 8.2.4.1. Absolute $ Opportunity
                 8.2.4.2. Market Value (US$ Mn) Forecast
                 8.2.4.3. Oncology
                 8.2.4.4. Immunology
                 8.2.4.5. Others
         8.2.5. Others
                 8.2.5.1. Absolute $ Opportunity
                 8.2.5.2. Market Value (US$ Mn) Forecast
   8.3. Market Attractiveness Analysis, By Application 

9. Global Glycobiology Market Analysis, By End User 
   9.1. Introduction
         9.1.1. Y-o-Y Growth Comparison, By End User 
         9.1.2. Market Share & Basis Point (BPS) Analysis, By End User 
   9.2. Market Forecast, By End User 
         9.2.1. Biopharmaceutical Companies
                 9.2.1.1. Absolute $ Opportunity
                 9.2.1.2. Market Value (US$ Mn) Forecast
         9.2.2. Research Laboratories
                 9.2.2.1. Absolute $ Opportunity
                 9.2.2.2. Market Value (US$ Mn) Forecast
         9.2.3. Hospitals
                 9.2.3.1. Absolute $ Opportunity
                 9.2.3.2. Market Value (US$ Mn) Forecast
         9.2.4. Diagnostic Centers
                 9.2.4.1. Absolute $ Opportunity
                 9.2.4.2. Market Value (US$ Mn) Forecast
         9.2.5. Contract Research Organizations
                 9.2.5.1. Absolute $ Opportunity
                 9.2.5.2. Market Value (US$ Mn) Forecast
         9.2.6. Biotechnology Industries
                 9.2.6.1. Absolute $ Opportunity
                 9.2.6.2. Market Value (US$ Mn) Forecast
         9.2.7. Academic Institutes
                 9.2.7.1. Absolute $ Opportunity
                 9.2.7.2. Market Value (US$ Mn) Forecast
         9.2.8. Others
                 9.2.8.1. Absolute $ Opportunity
                 9.2.8.2. Market Value (US$ Mn) Forecast
   9.3. Market Attractiveness Analysis, By End User 

10. Global Glycobiology Market Analysis, By Region
   10.1. Introduction
         10.1.1. Y-o-Y Growth Projections, By Region
         10.1.2. Market Share & Basis Point (BPS) Analysis, By Region
   10.2. Market Forecast, By Region
         10.2.1. North America Market Value (US$ Mn) Forecast
         10.2.2. Latin America Market Value (US$ Mn) Forecast
         10.2.3. Europe Market Value (US$ Mn) Forecast
         10.2.4. APAC Market Value (US$ Mn) Forecast
         10.2.5. MEA Market Value (US$ Mn) Forecast
   10.3. Regional Attractiveness Analysis

11. North America Glycobiology Market Analysis
   11.1. Introduction
         11.1.1. Y-o-Y Growth Projections, By Country
         11.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   11.2. Key Trends
   11.3. North America Market Forecast
         11.3.1. Market Value (US$ Mn) Forecast, By Country
                 11.3.1.1. U.S. Absolute $ Opportunity
                 11.3.1.2. Canada Absolute $ Opportunity
         11.3.2. Market Value (US$ Mn) Forecast, By Product Type 
                 11.3.2.1. Instruments
                 11.3.2.2. Enzymes
                 11.3.2.3. Consumables
                 11.3.2.4. Reagent Kits
         11.3.3. Market Value (US$ Mn) Forecast, By Enzyme 
                 11.3.3.1. Galactosidases
                           11.3.3.1.1. Fucosidases
                           11.3.3.1.2. Chitinases
                           11.3.3.1.3. cetylgalactosaminidase
                           11.3.3.1.4. Heparinase
                           11.3.3.1.5. PNGase F
                           11.3.3.1.6. Others
                 11.3.3.2. GlcNAc Transferases
                           11.3.3.2.1. Acetylglucosaminyltransferase
                           11.3.3.2.2. Exostosin
                           11.3.3.2.3. Others
                 11.3.3.3. Fucosyltransferases
                 11.3.3.4. GalNAc Transferases
                 11.3.3.5. Galactosyl Transferases
                 11.3.3.6. Glucuronosyltransferases
                 11.3.3.7. Glucosyltransferases
                 11.3.3.8. Pentosyltransferases
                 11.3.3.9. Carbohydrate Kinases
                 11.3.3.10. Neuraminidases
                 11.3.3.11. Sialyltransferases
                 11.3.3.12. Others
         11.3.4. Market Value (US$ Mn) Forecast, By Application 
                 11.3.4.1. Drug Discovery And Development
                 11.3.4.2. Diagnostic Applications
                           11.3.4.2.1. Oncology
                           11.3.4.2.2. Immunology
                           11.3.4.2.3. Others
                 11.3.4.3. Industrial Application
                 11.3.4.4. Therapeutic Application
                           11.3.4.4.1. Oncology
                           11.3.4.4.2. Immunology
                           11.3.4.4.3. Others
                 11.3.4.5. Others
         11.3.5. Market Value (US$ Mn) Forecast, By End User 
                 11.3.5.1. Biopharmaceutical Companies
                 11.3.5.2. Research Laboratories
                 11.3.5.3. Hospitals
                 11.3.5.4. Diagnostic Centers
                 11.3.5.5. Contract Research Organizations
                 11.3.5.6. Biotechnology Industries
                 11.3.5.7. Academic Institutes
                 11.3.5.8. Others
   11.4. Market Attractiveness Analysis
         11.4.1. By Country
         11.4.2. By Product Type 
         11.4.3. By End User 
         11.4.4. By Enzyme 
         11.4.5. By Application 

12. Latin America Glycobiology Market Analysis
   12.1. Introduction
         12.1.1. Y-o-Y Growth Projections, By Country
         12.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   12.2. Key Trends
   12.3. Latin America Market Forecast
         12.3.1. Market Value (US$ Mn) Forecast, By Country
                 12.3.1.1. Brazil Absolute $ Opportunity
                 12.3.1.2. Mexico Absolute $ Opportunity
                 12.3.1.3. Rest of Latin America Absolute $ Opportunity
         12.3.2. Market Value (US$ Mn) Forecast, By Product Type 
                 12.3.2.1. Instruments
                 12.3.2.2. Enzymes
                 12.3.2.3. Consumables
                 12.3.2.4. Reagent Kits
         12.3.3. Market Value (US$ Mn) Forecast, By Enzyme 
                 12.3.3.1. Galactosidases
                           12.3.3.1.1. Fucosidases
                           12.3.3.1.2. Chitinases
                           12.3.3.1.3. cetylgalactosaminidase
                           12.3.3.1.4. Heparinase
                           12.3.3.1.5. PNGase F
                           12.3.3.1.6. Others
                 12.3.3.2. GlcNAc Transferases
                           12.3.3.2.1. Acetylglucosaminyltransferase
                           12.3.3.2.2. Exostosin
                           12.3.3.2.3. Others
                 12.3.3.3. Fucosyltransferases
                 12.3.3.4. GalNAc Transferases
                 12.3.3.5. Galactosyl Transferases
                 12.3.3.6. Glucuronosyltransferases
                 12.3.3.7. Glucosyltransferases
                 12.3.3.8. Pentosyltransferases
                 12.3.3.9. Carbohydrate Kinases
                 12.3.3.10. Neuraminidases
                 12.3.3.12. Sialyltransferases
                 12.3.3.12. Others
         12.3.4. Market Value (US$ Mn) Forecast, By Application 
                 12.3.4.1. Drug Discovery And Development
                 12.3.4.2. Diagnostic Applications
                           12.3.4.2.1. Oncology
                           12.3.4.2.2. Immunology
                           12.3.4.2.3. Others
                 12.3.4.3. Industrial Application
                 12.3.4.4. Therapeutic Application
                           12.3.4.4.1. Oncology
                           12.3.4.4.2. Immunology
                           12.3.4.4.3. Others
                 12.3.4.5. Others
         12.3.5. Market Value (US$ Mn) Forecast, By End User 
                 12.3.5.1. Biopharmaceutical Companies
                 12.3.5.2. Research Laboratories
                 12.3.5.3. Hospitals
                 12.3.5.4. Diagnostic Centers
                 12.3.5.5. Contract Research Organizations
                 12.3.5.6. Biotechnology Industries
                 12.3.5.7. Academic Institutes
                 12.3.5.8. Others
   12.4. Market Attractiveness Analysis
         12.4.1. By Country
         12.4.2. By Product Type 
         12.4.3. By End User 
         12.4.4. By Enzyme 
         12.4.5. By Application 

13. Europe Glycobiology Market Analysis
   13.1. Introduction
         13.1.1. Y-o-Y Growth Projections, By Country
         13.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   13.2. Key Trends
   13.3. Europe Market Forecast
         13.3.1. Market Value (US$ Mn) Forecast, By Country
                 13.3.1.1. Germany Absolute $ Opportunity
                 13.3.1.2. U.K. Absolute $ Opportunity
                 13.3.1.3. France Absolute $ Opportunity
                 13.3.1.4. Italy Absolute $ Opportunity
                 13.3.1.5. Spain Absolute $ Opportunity
                 13.3.1.6. Russia Absolute $ Opportunity
                 13.3.1.7. Rest of Europe Absolute $ Opportunity
         13.3.2. Market Value (US$ Mn) Forecast, By Product Type 
                 13.3.2.1. Instruments
                 13.3.2.2. Enzymes
                 13.3.2.3. Consumables
                 13.3.2.4. Reagent Kits
         13.3.3. Market Value (US$ Mn) Forecast, By Enzyme 
                 13.3.3.1. Galactosidases
                           13.3.3.1.1. Fucosidases
                           13.3.3.1.2. Chitinases
                           13.3.3.1.3. cetylgalactosaminidase
                           13.3.3.1.4. Heparinase
                           13.3.3.1.5. PNGase F
                           13.3.3.1.6. Others
                 13.3.3.2. GlcNAc Transferases
                           13.3.3.2.1. Acetylglucosaminyltransferase
                           13.3.3.2.2. Exostosin
                           13.3.3.2.3. Others
                 13.3.3.3. Fucosyltransferases
                 13.3.3.4. GalNAc Transferases
                 13.3.3.5. Galactosyl Transferases
                 13.3.3.6. Glucuronosyltransferases
                 13.3.3.7. Glucosyltransferases
                 13.3.3.8. Pentosyltransferases
                 13.3.3.9. Carbohydrate Kinases
                 13.3.3.10. Neuraminidases
                 13.3.3.13. Sialyltransferases
                 13.3.3.12. Others
         13.3.4. Market Value (US$ Mn) Forecast, By Application 
                 13.3.4.1. Drug Discovery And Development
                 13.3.4.2. Diagnostic Applications
                           13.3.4.2.1. Oncology
                           13.3.4.2.2. Immunology
                           13.3.4.2.3. Others
                 13.3.4.3. Industrial Application
                 13.3.4.4. Therapeutic Application
                           13.3.4.4.1. Oncology
                           13.3.4.4.2. Immunology
                           13.3.4.4.3. Others
                 13.3.4.5. Others
         13.3.5. Market Value (US$ Mn) Forecast, By End User 
                 13.3.5.1. Biopharmaceutical Companies
                 13.3.5.2. Research Laboratories
                 13.3.5.3. Hospitals
                 13.3.5.4. Diagnostic Centers
                 13.3.5.5. Contract Research Organizations
                 13.3.5.6. Biotechnology Industries
                 13.3.5.7. Academic Institutes
                 13.3.5.8. Others
   13.4. Market Attractiveness Analysis
         13.4.1. By Country
         13.4.2. By Product Type 
         13.4.3. By End User 
         13.4.4. By Enzyme 
         13.4.5. By Application 

14. APAC Glycobiology Market Analysis
   14.1. Introduction
         14.1.1. Y-o-Y Growth Projections, By Country
         14.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   14.2. Key Trends
   14.3. APAC Market Forecast
         14.3.1. Market Value (US$ Mn) Forecast, By Country
                 14.3.1.1. China Absolute $ Opportunity
                 14.3.1.2. Japan Absolute $ Opportunity
                 14.3.1.3. Australia & New Zealand Absolute $ Opportunity
                 14.3.1.4. ASEAN Absolute $ Opportunity
                 14.3.1.5. India Absolute $ Opportunity
                 14.3.1.6. Rest of APAC Absolute $ Opportunity
         14.3.2. Market Value (US$ Mn) Forecast, By Product Type 
                 14.3.2.1. Instruments
                 14.3.2.2. Enzymes
                 14.3.2.3. Consumables
                 14.3.2.4. Reagent Kits
         14.3.3. Market Value (US$ Mn) Forecast, By Enzyme 
                 14.3.3.1. Galactosidases
                           14.3.3.1.1. Fucosidases
                           14.3.3.1.2. Chitinases
                           14.3.3.1.3. cetylgalactosaminidase
                           14.3.3.1.4. Heparinase
                           14.3.3.1.5. PNGase F
                           14.3.3.1.6. Others
                 14.3.3.2. GlcNAc Transferases
14.3.3.2.1. Acetylglucosaminyltransferase
14.3.3.2.2. Exostosin
14.3.3.2.3. Others
                 14.3.3.3. Fucosyltransferases
                 14.3.3.4. GalNAc Transferases
                 14.3.3.5. Galactosyl Transferases
                 14.3.3.6. Glucuronosyltransferases
                 14.3.3.7. Glucosyltransferases
                 14.3.3.8. Pentosyltransferases
                 14.3.3.9. Carbohydrate Kinases
                 14.3.3.10. Neuraminidases
                 14.3.3.14. Sialyltransferases
                 14.3.3.12. Others
         14.3.4. Market Value (US$ Mn) Forecast, By Application 
                 14.3.4.1. Drug Discovery And Development
                 14.3.4.2. Diagnostic Applications
                           14.3.4.2.1. Oncology
                           14.3.4.2.2. Immunology
                           14.3.4.2.3. Others
                 14.3.4.3. Industrial Application
                 14.3.4.4. Therapeutic Application
                           14.3.4.4.1. Oncology
                           14.3.4.4.2. Immunology
                           14.3.4.4.3. Others
                 14.3.4.5. Others
         14.3.5. Market Value (US$ Mn) Forecast, By End User 
                 14.3.5.1. Biopharmaceutical Companies
                 14.3.5.2. Research Laboratories
                 14.3.5.3. Hospitals
                 14.3.5.4. Diagnostic Centers
                 14.3.5.5. Contract Research Organizations
                 14.3.5.6. Biotechnology Industries
                 14.3.5.7. Academic Institutes
                 14.3.5.8. Others
   14.4. Market Attractiveness Analysis
         14.4.1. By Country
         14.4.2. By Product Type 
         14.4.3. By End User 
         14.4.4. By Enzyme 
         14.4.5. By Application 

15. MEA Glycobiology Market Analysis
   15.1. Introduction
         15.1.1. Y-o-Y Growth Projections, By Country
         15.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   15.2. Key Trends
   15.3. MEA Market Forecast
         15.3.1. Market Value (US$ Mn) Forecast, By Country
                 15.3.1.1. GCC Countries Absolute $ Opportunity
                 15.3.1.2. South Africa Absolute $ Opportunity
                 15.3.1.3. Rest of MEA Absolute $ Opportunity
         15.3.2. Market Value (US$ Mn) Forecast, By Product Type 
                 15.3.2.1. Instruments
                 15.3.2.2. Enzymes
                 15.3.2.3. Consumables
                 15.3.2.4. Reagent Kits
         15.3.3. Market Value (US$ Mn) Forecast, By Enzyme 
                 15.3.3.1. Galactosidases
                           15.3.3.1.1. Fucosidases
                           15.3.3.1.2. Chitinases
                           15.3.3.1.3. cetylgalactosaminidase
                           15.3.3.1.4. Heparinase
                           15.3.3.1.5. PNGase F
                           15.3.3.1.6. Others
                 15.3.3.2. GlcNAc Transferases
                           15.3.3.2.1. Acetylglucosaminyltransferase
                           15.3.3.2.2. Exostosin
                           15.3.3.2.3. Others
                 15.3.3.3. Fucosyltransferases
                 15.3.3.4. GalNAc Transferases
                 15.3.3.5. Galactosyl Transferases
                 15.3.3.6. Glucuronosyltransferases
                 15.3.3.7. Glucosyltransferases
                 15.3.3.8. Pentosyltransferases
                 15.3.3.9. Carbohydrate Kinases
                 15.3.3.10. Neuraminidases
                 15.3.3.15. Sialyltransferases
                 15.3.3.12. Others
         15.3.4. Market Value (US$ Mn) Forecast, By Application 
                 15.3.4.1. Drug Discovery And Development
                 15.3.4.2. Diagnostic Applications
                           15.3.4.2.1. Oncology
                           15.3.4.2.2. Immunology
                           15.3.4.2.3. Others
                 15.3.4.3. Industrial Application
                 15.3.4.4. Therapeutic Application
                           15.3.4.4.1. Oncology
                           15.3.4.4.2. Immunology
                           15.3.4.4.3. Others
                 15.3.4.5. Others
         15.3.5. Market Value (US$ Mn) Forecast, By End User 
                 15.3.5.1. Biopharmaceutical Companies
                 15.3.5.2. Research Laboratories
                 15.3.5.3. Hospitals
                 15.3.5.4. Diagnostic Centers
                 15.3.5.5. Contract Research Organizations
                 15.3.5.6. Biotechnology Industries
                 15.3.5.7. Academic Institutes
                 15.3.5.8. Others
   15.4. Market Attractiveness Analysis
         15.4.1. By Country
         15.4.2. By Product Type 
         15.4.3. By End User 
         15.4.4. By Enzyme 
         15.4.5. By Application 

16. Competitive Landscape
   16.1. Competition Dashboard
   16.2. Company Share Analysis (2015)
   16.3. Company Profiles Inclusions
         16.3.1. Revenue
         16.3.2. Products/Brand Offerings
         16.3.3. Key developments
         16.3.4. SWOT Analysis
   16.4. Company Profiled
         16.4.1. Merck KGaA 
         16.4.2. Bio-Techne Corporation 
         16.4.3. Bruker Corporation 
         16.4.4. Thermo Fisher Scientific, Inc. 
         16.4.5. Shimadzu Corporation 
         16.4.6. Plexera Bioscience LLC 
         16.4.7. New England Biolabs Inc. 
         16.4.8. Agilent Technologies, Inc. 
         16.4.9. ProZyme, Inc. 


List of Tables:

Table 01: Global Glycobiology Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 02: Global Glycobiology Market Value (US$ Mn) Analysis and Forecast By Enzymes Sub-segment, 2015–2024
Table 03: Global Glycobiology Market Value (US$ Mn) Analysis and Forecast By Galactosidases and GlcNAc Transferases Enzymes Category, 2015–2024
Table 04: Global Glycobiology Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 05: Global Glycobiology Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024
Table 06: Global Glycobiology Market Value (US$ Mn) Analysis and Forecast By Region, 2015–2024
Table 07: North America Glycobiology Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 08: North America Glycobiology Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 09: North America Glycobiology Market Value (US$ Mn) Analysis and Forecast By Enzymes Sub-segment, 2015–2024
Table 10: North America Glycobiology Market Value (US$ Mn) Analysis and Forecast By Galactosidases and GlcNAc Transferases Enzymes Categories, 2015–2024
Table 11: North America Glycobiology Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 12: North America Glycobiology Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024
Table 13: Latin America Glycobiology Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 14: Latin America Glycobiology Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 15: Latin America Glycobiology Market Value (US$ Mn) Analysis and Forecast By Enzymes Sub-segments, 2015–2024
Table 16: Latin America Glycobiology Market Value (US$ Mn) Analysis and Forecast By Galactosidases and GlcNAc Transferases Enzymes Categories, 2015–2024
Table 17: Latin America Glycobiology Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 18: Latin America Glycobiology Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024
Table 19: Europe Glycobiology Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 20: Europe Glycobiology Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 21: Europe Glycobiology Market Value (US$ Mn) Analysis and Forecast By Enzymes Sub-segment, 2015–2024
Table 22: Europe Glycobiology Market Value (US$ Mn) Analysis and Forecast By Galactosidases and GlcNAc Transferases Enzymes Categories, 2015–2024
Table 23: Europe Glycobiology Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 24: Europe Glycobiology Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024
Table 25: APAC Glycobiology Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 26: APAC Glycobiology Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 27: APAC Glycobiology Market Value (US$ Mn) Analysis and Forecast By Enzymes Sub-segments, 2015–2024
Table 28: APAC Glycobiology Market Value (US$ Mn) Analysis and Forecast By Galactosidases and GlcNAc Transferases Enzymes Categories, 2015–2024
Table 29: APAC Glycobiology Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 30: APAC Glycobiology Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024
Table 31: MEA Glycobiology Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 32: MEA Glycobiology Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 33: MEA Glycobiology Market Value (US$ Mn) Analysis and Forecast By Enzymes Sub-segments, 2015–2024
Table 34: MEA Glycobiology Market Value (US$ Mn) Analysis and Forecast By Galactosidases and GlcNAc Transferases Enzymes Categories, 2015–2024
Table 35: MEA Glycobiology Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 36: MEA Glycobiology Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024


List of Figures:

Figure 01: Global Glycobiology Market – Scenario Forecast, 2015–2024 (US$ Mn)
Figure 02: Global Glycobiology Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 03: Global Glycobiology Market Absolute $ Opportunity, 2016–2024 
Figure 04: Global Glycobiology Reagent Kits Price Difference (US$) By Region, 2015
Figure 05: Global Glycobiology Reagent Kits Price Difference (US$) By Region, 2024
Figure 06: Global Glycobiology Enzymes Price Difference (US$) By Region, 2015
Figure 07: Global Glycobiology Enzymes Price Difference (US$) By Region, 2024
Figure 08: Global Glycobiology Instruments Price Difference (US$) By Region, 2015
Figure 09: Global Glycobiology Instruments Price Difference (US$) By Region, 2024
Figure 10: Global Glycobiology Market Share Analysis (%) By Product Type, 2016 & 2024
Figure 11: Global Glycobiology Y-o-Y growth (%) By Product Type, 2016–2024
Figure 12: Global Glycobiology Market Absolute $ Opportunity By Instruments Product Type Segment, 2016–2024
Figure 13: Global Glycobiology Market Absolute $ Opportunity By Enzymes Product Type Segment, 2016–2024
Figure 14: Global Glycobiology Market Absolute $ Opportunity By Consumables Product Type Segment, 2016–2024
Figure 15: Global Glycobiology Market Absolute $ Opportunity By Reagent Kits Product Type Segment, 2016–2024
Figure 16: Global Glycobiology Market Attractiveness Analysis By Product Type, 2016–2024
Figure 17: Global Glycobiology Market Share Analysis (%) By Enzymes, 2016 & 2024
Figure 18: Global Glycobiology Y-o-Y growth (%) By Enzymes, 2016–2024
Figure 19: Global Glycobiology Market Absolute $ Opportunity By Galactosidases Enzymes Segment, 2016–2024
Figure 20: Global Glycobiology Market Absolute $ Opportunity By GlcNAc Transferases Enzymes Segment, 2016–2024
Figure 21: Global Glycobiology Market Absolute $ Opportunity By Fucosyltransferases Enzymes Segment, 2016–2024
Figure 22: Global Glycobiology Market Absolute $ Opportunity By GalNAc Transferases Enzymes Segment, 2016–2024
Figure 23: Global Glycobiology Market Absolute $ Opportunity By Galactosyl Transferases Enzymes Segment, 2016–2024
Figure 24: Global Glycobiology Market Absolute $ Opportunity By Glucuronosyltransferases Enzymes Segment, 2016–2024
Figure 25: Global Glycobiology Market Absolute $ Opportunity By Glucosyltransferases Enzymes Segment, 2016–2024
Figure 26: Global Glycobiology Market Absolute $ Opportunity By Pentosyltransferases Enzymes Segment, 2016–2024
Figure 27: Global Glycobiology Market Absolute $ Opportunity By Carbohydrate Kinases Enzymes Segment, 2016–2024
Figure 28: Global Glycobiology Market Absolute $ Opportunity By Neuraminidases Enzymes Segment, 2016–2024
Figure 29: Global Glycobiology Market Absolute $ Opportunity By Sialyltransferases Enzymes Segment, 2016–2024
Figure 30: Global Glycobiology Market Absolute $ Opportunity By Others Enzymes Segment, 2016–2024
Figure 31: Global Glycobiology Market Attractiveness Analysis By Enzymes, 2016–2024
Figure 32: Global Glycobiology Market Share Analysis (%) By Application, 2016 & 2024
Figure 33: Global Glycobiology Y-o-Y growth (%) By Application, 2016–2024
Figure 34: Global Glycobiology Market Absolute $ Opportunity By Drug Discovery and Development Application Segment, 2016–2024
Figure 35: Global Glycobiology Market Absolute $ Opportunity By Diagnostic Application Segment, 2016–2024
Figure 36: Global Glycobiology Market Absolute $ Opportunity By Industrial Application Segment, 2016–2024
Figure 37: Global Glycobiology Market Absolute $ Opportunity By Therapeutic Application Segment, 2016–2024
Figure 38: Global Glycobiology Market Absolute $ Opportunity By Others Application Segment, 2016–2024
Figure 39: Global Glycobiology Market Attractiveness Analysis By Application, 2016–2024
Figure 40: Global Glycobiology Market Share Analysis (%) By End User, 2016 & 2024
Figure 41: Global Glycobiology Y-o-Y growth (%) By End User, 2016–2024
Figure 42: Global Glycobiology Market Absolute $ Opportunity By Biopharmaceutical Companies End User Segment, 2016–2024
Figure 43: Global Glycobiology Market Absolute $ Opportunity By Research Laboratories End User Segment, 2016–2024
Figure 44: Global Glycobiology Market Absolute $ Opportunity By Hospitals End User Segment, 2016–2024
Figure 45: Global Glycobiology Market Absolute $ Opportunity By Diagnostic Centers End User Segment, 2016–2024
Figure 46: Global Glycobiology Market Absolute $ Opportunity By Contract Research Organizations End User Segment, 2016–2024
Figure 47: Global Glycobiology Market Absolute $ Opportunity By Biotechnology Industries End User Segment, 2016–2024
Figure 48: Global Glycobiology Market Absolute $ Opportunity By Academic Institutes End User Segment, 2016–2024
Figure 49: Global Glycobiology Market Absolute $ Opportunity By Others End User Segment, 2016–2024
Figure 50: Global Glycobiology Market Attractiveness Analysis By End User, 2016–2024
Figure 51: Global Glycobiology Market Value (US$ Mn) and CAGR (%) By Region, 2015, 2020, and 2024
Figure 52: Global Glycobiology Market Share Analysis (%) By Region, 2016 & 2024
Figure 53: Global Glycobiology Y-o-Y growth (%) By Region, 2016–2024
Figure 54: North America Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 55: Latin America Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 56: Europe Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 57: APAC Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 58: MEA Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 59: Global Glycobiology Market Attractiveness Analysis By Region, 2016–2024
Figure 60: North America Glycobiology Market Share Analysis (%) By Country, 2016 & 2024
Figure 61: North America Glycobiology Y-o-Y growth (%) By Country, 2016–2024
Figure 62: North America Glycobiology Market Attractiveness Analysis By Country, 2016–2024
Figure 63: U.S. Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 64: Canada Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 65: North America Glycobiology Market Attractiveness Analysis By Product Type, 2016–2024
Figure 66: North America Glycobiology Market Attractiveness Analysis By Enzymes Sub-segments, 2016–2024
Figure 67: North America Glycobiology Market Attractiveness Analysis By Application, 2016–2024
Figure 68: North America Glycobiology Market Attractiveness Analysis By End User, 2016–2024
Figure 69: Latin America Glycobiology Market Share Analysis (%) By Country, 2016 & 2024
Figure 70: Latin America Glycobiology Y-o-Y growth (%) By Country, 2016–2024
Figure 71: Latin America Glycobiology Market Attractiveness Analysis By Country, 2016–2024
Figure 72: Brazil Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 73: Mexico Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 74: Rest of Latin America Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 75: Latin America Glycobiology Market Attractiveness Analysis By Product Type, 2016–2024
Figure 76: Latin America Glycobiology Market Attractiveness Analysis By Enzymes Sub-segments, 2016–2024
Figure 77: Latin America Glycobiology Market Attractiveness Analysis By Application, 2016–2024
Figure 78: Latin America Glycobiology Market Attractiveness Analysis By End User, 2016–2024
Figure 79: Europe Glycobiology Market Share Analysis (%) By Country, 2016 & 2024
Figure 80: Europe Glycobiology Y-o-Y growth (%) By Country, 2016–2024
Figure 81: Europe Glycobiology Market Attractiveness Analysis By Country,
Figure 82: Germany Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 83: U.K. Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 84: France Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 85: Italy Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 86: Spain Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 87: Russia Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 88: Rest of Europe Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 89: Europe Glycobiology Market Attractiveness Analysis By Product Type, 2016–2024
Figure 90: Europe Glycobiology Market Attractiveness Analysis By Enzymes Sub-segments, 2016–2024
Figure 91: Europe Glycobiology Market Attractiveness Analysis By Application, 2016–2024
Figure 92: Europe Glycobiology Market Attractiveness Analysis By End User, 2016–2024
Figure 93: APAC Glycobiology Market Share Analysis (%) By Country, 2016 & 2024
Figure 94: APAC Glycobiology Y-o-Y growth (%) By Country, 2016–2024
Figure 95: APAC Glycobiology Market Attractiveness Analysis By Country,
Figure 96: China Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 97: Japan Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 98:Australia & New Zealand Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 99: ASEAN Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 100: India Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 101: Rest of APAC Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 102: APAC Glycobiology Market Attractiveness Analysis By Product Type, 2016–2024
Figure 103: APAC Glycobiology Market Attractiveness Analysis By Enzymes Sub-segments, 2016–2024
Figure 104: APAC Glycobiology Market Attractiveness Analysis By Application, 2016–2024
Figure 105: APAC Glycobiology Market Attractiveness Analysis By End User, 2016–2024
Figure 106: MEA Glycobiology Market Share Analysis (%) By Country, 2016 & 2024
Figure 107: MEA Glycobiology Y-o-Y growth (%) By Country, 2016–2024
Figure 108: MEA Glycobiology Market Attractiveness Analysis By Country,
Figure 109: GCC Countries Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 110: South Africa Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 111: Rest of MEA Glycobiology Market Absolute $ Opportunity, 2016–2024
Figure 112: MEA Glycobiology Market Attractiveness Analysis By Product Type, 2016–2024
Figure 113: MEA Glycobiology Market Attractiveness Analysis By Enzymes Sub-segments, 2016–2024
Figure 114: MEA Glycobiology Market Attractiveness Analysis By Application, 2016–2024
Figure 115: MEA Glycobiology Market Attractiveness Analysis By End User, 2016–2024
Figure 116: Global Glycobiology Company Market Share Analysis, 2014